-

Everlywell Reports Nearly 50% Member Engagement and 10% Care Activation Increases with Eva Engage, AI Health Companion, Compared to Traditional Outreach

Eva delivers care navigation and support that meets rigorous quality benchmarks at scale

AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today reported new insights from Eva Engage, the personalized outreach capability within Eva, its AI health companion launched earlier this year. Eva is powered by three core engines, Eva Engage, Eva Care, and Eva Support, that create an intelligent, connected care experience, helping individuals take meaningful action for their health.

Eva Engage is more proactive, timely, and deeply personal than traditional outreach. Its AI capability anticipates member needs and initiates the right touchpoint at the right time, while advanced AI Voice Agent technology delivers natural, human-like conversations across languages. For enterprise partners, it seamlessly scales personalized member engagement across large populations with far less operational burden.

Early findings from a program with a national health plan show the transformational impact of Eva Engage. Leveraging Eva Engage’s AI Voice Agent functionality, Everlywell placed 60,000 member calls, which drove nearly 50% higher member engagement and 10% increase in care activation compared to traditional Interactive Voice Response (IVR). Engagement among Spanish-preferred members was particularly strong, with more than double the engagement rate and triple the order completion rate of non-Spanish-preferred members, demonstrating the value of seamless multilingual and personalized outreach at scale.

“Eva Engage is already showing what happens when you combine conversational AI with clinical intelligence and billions of engagement data points,” said Blake Lusenhop, Head of Technology at Everlywell. “These early results are confirming what we believed from the start: when outreach feels personal, relevant, and trustworthy, people take action. AI can deliver that experience at a scale traditional systems simply can’t.”

While Eva Engage has outpaced traditional IVR, our data also show that AI engagement is performing at least as well as live human care navigation and support, and doing so with far greater efficiency. Nearly 70% of Eva Engage interactions end in successful resolution. In healthcare support, a 70% first-contact-resolution rate is considered a strong industry benchmark, typically achieved by trained human teams.1 Eva Engage is already meeting that standard, and this is just the start.

By helping partners reach members with precision and impact, Eva Engage accelerates Everlywell’s mission to advance proactive, personalized care, and reinforces the company’s role as a trusted partner for companies pushing the future of healthcare.

About Everlywell

Everlywell is a digital health company pioneering the next generation of biomarker intelligence—combining AI-powered technology with human insight to deliver personalized, actionable health answers. Everlywell transforms complex biomarker data into life-changing insights, seamlessly integrating advanced diagnostics, virtual care, and patient engagement to reshape how and where health happens.

Over the past decade, Everlywell has delivered nearly 1 billion personalized health insights, transformed care for 60 million people and powered hundreds of enterprise partners, including 4 of the 5 largest health plans in the U.S. that cover 170 million insured lives. In 2024 alone, an estimated 1 in 86 U.S. households received an Everlywell test, solidifying its spot as the #1 at-home testing company in the country. Fueled by AI and built for scale, Everlywell is breaking down barriers, closing care gaps, and unlocking a more connected healthcare experience that is smarter, faster, and more personalized. Learn more at everlywell.com.

References

  1. Zendesk. “What is first contact resolution (FCR)? Benefits + best practices.” August 2025.

Contacts

Jensen Cannon, Everlywell
media@everlywell.com

Everlywell


Release Versions

Contacts

Jensen Cannon, Everlywell
media@everlywell.com

More News From Everlywell

Everlywell Launches Next-Gen AI Health Platform Eva to Power Smarter, Scalable Care

AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today announced the launch of Eva—an AI-powered platform that turns complex biomarker data into easy-to-understand, personalized health insights. Eva combines intelligence with engaging tools to guide and motivate individuals to take meaningful action for their health. Eva is an intelligent health companion that helps personalize crucial touchpoints with smart recommendations and insights throughout the healthcare journey,...

On Inaugural National Get Tested Day, The American Sexual Health Association and Everlywell Partner to Provide Access to STI Testing

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The American Sexual Health Association (ASHA), America’s nonprofit authority for sexual health information, is launching its inaugural National Get Tested Day on September 30 to advance the conversation around sexual health and break down barriers to accessing this essential health care. On the launch of National Get Tested Day, ASHA is partnering with Everlywell, a leader in at-home STI lab testing and treatment, to give away 250 free Everlywell a...

Everly Health and National Kidney Foundation Partnership Aims to Save Lives Through Early Detection of Chronic Kidney Disease

AUSTIN, Texas--(BUSINESS WIRE)--Everly Health, a leading remote-based healthcare company expanding access to virtual-first disease prevention, diagnosis, and treatment, today announced an educational partnership with the National Kidney Foundation aimed at informing Americans about chronic kidney disease and increasing access to screening in rural and underserved communities across the United States. Kidney disease affects 37 million adults in the United States but 90% are unaware they even hav...
Back to Newsroom